+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infection Surveillance Solution Market - Global Forecast 2026-2032- Product Image
Infection Surveillance Solution Market - Global Forecast 2026-2032- Product Image
Sale

Infection Surveillance Solution Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5012974
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Infection Surveillance Solution Market is projected to reach USD 1.09 Billion in 2026. It is expected to continue growing at a CAGR of 14.00%, reaching USD 2.44 Billion by 2032.

Infection surveillance solutions are becoming core infrastructure for hospitals, laboratories, long-term care facilities, and public health agencies as healthcare systems respond to healthcare-associated infections, antimicrobial resistance, and emerging pathogens. The WHO reports that 7 in 100 patients in high-income countries and 15 in 100 patients in low- and middle-income countries acquire at least one healthcare-associated infection during acute care, while the CDC estimates that about 1 in 31 U.S. hospital patients has at least one healthcare-associated infection on any given day.

Modern infection surveillance platforms integrate electronic health records, laboratory information systems, pharmacy data, admission-discharge-transfer feeds, microbiology results, and case reporting workflows to accelerate detection, investigation, and prevention. Demand is rising for automated infection prevention software, real-time outbreak monitoring, antimicrobial stewardship analytics, and interoperable reporting tools that reduce manual chart review, improve regulatory readiness, and strengthen patient safety programs.

Transformative Shifts in the Infection Surveillance Landscape

The infection surveillance landscape is shifting from retrospective compliance reporting to continuous, data-driven prevention. Healthcare organizations are replacing spreadsheet-based infection tracking with automated surveillance engines that identify clusters, flag multidrug-resistant organisms, monitor device-associated infections, and support timely interventions across inpatient, outpatient, and community settings.

Regulatory pressure and global preparedness priorities are also reshaping adoption. CDC NHSN reporting, ECDC HAI-Net surveillance, WHO GLASS antimicrobial resistance monitoring, and national digital health programs are encouraging standardized definitions, interoperable data exchange, and auditable infection prevention workflows. At the same time, cloud deployment, API-based integration, data quality management, and cybersecurity-by-design are becoming essential buying criteria for healthcare IT leaders.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the value of infection surveillance by improving early signal detection, risk stratification, and workload prioritization. Machine learning models can analyze microbiology results, antibiotic orders, device utilization, patient movement, and clinical notes to identify patterns that may be missed during manual review. Natural language processing is increasingly used to extract infection-relevant context from unstructured clinical documentation, including progress notes, radiology narratives, and discharge summaries.

The cumulative impact of AI is strongest when algorithms are clinically validated, explainable, and embedded into infection prevention workflows. AI-enabled surveillance can support faster outbreak recognition, more targeted isolation precautions, better antimicrobial stewardship, and more consistent reporting, but implementation requires strong data governance, bias monitoring, privacy controls, cybersecurity safeguards, and human oversight to ensure patient safety and regulatory trust.

Key Regional Insights

North America remains a leading region for infection surveillance solution adoption, supported by mature EHR penetration, CDC NHSN reporting requirements, antimicrobial stewardship mandates, and strong investment in hospital quality improvement. Europe benefits from ECDC-led surveillance networks, national infection control programs, and European Union digital health interoperability priorities, with demand concentrated around standardized reporting, privacy-compliant analytics, and cross-border preparedness. Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN health systems invest in hospital digitization, laboratory modernization, and infectious disease preparedness.

Latin America shows growing demand in Brazil and Mexico as private hospital networks and public health agencies strengthen infection control capacity, antimicrobial resistance monitoring, and accreditation-driven quality programs. The Middle East, particularly GCC markets, is adopting advanced surveillance across smart hospitals and digitally connected health systems, with emphasis on rapid outbreak detection and centralized dashboards. Africa is prioritizing scalable, laboratory-linked surveillance to address outbreak response, antimicrobial resistance, and resource-constrained infection prevention, supported by regional public health initiatives and investments in disease monitoring infrastructure.

Key Group Insights

ASEAN countries are strengthening infection surveillance through hospital accreditation, regional disease monitoring, and investments in digital health infrastructure, with adoption shaped by varying levels of EHR maturity and laboratory connectivity. The GCC is advancing high-acuity, technology-enabled healthcare systems, making cloud-based infection prevention platforms, outbreak dashboards, and antimicrobial stewardship tools increasingly relevant for public and private hospitals. The European Union emphasizes cross-border data standards, privacy compliance, and coordinated infection monitoring, creating demand for interoperable and GDPR-aligned platforms that support national and regional reporting frameworks.

BRICS countries represent high-volume opportunities due to large patient populations, expanding hospital networks, and rising antimicrobial resistance surveillance needs across complex public and private care systems. G7 markets lead in advanced analytics, regulatory reporting, clinical validation, and integrated quality improvement, supporting adoption of automated infection surveillance software and AI-enabled decision support. NATO members increasingly view infectious disease surveillance as part of health security, resilience planning, military medical readiness, and emergency preparedness, reinforcing the need for secure, interoperable, and rapidly deployable surveillance systems.

Key Country Insights

The United States leads demand through CDC NHSN participation, quality reporting, antimicrobial stewardship requirements, and integrated hospital IT ecosystems, while Canada emphasizes provincial surveillance, patient safety, and coordinated infection prevention programs. Mexico and Brazil are strengthening hospital infection control programs as healthcare modernization, accreditation, and public health reporting needs accelerate. In Europe, the United Kingdom, Germany, France, Italy, and Spain prioritize standardized reporting, infection prevention performance, and privacy-compliant data exchange, while Russia maintains demand for infectious disease monitoring across large regional health systems and centralized public health structures.

China and India represent major growth markets due to large hospital networks, rising digital health investment, laboratory expansion, and heightened focus on antimicrobial resistance. Japan, South Korea, and Australia show strong readiness for AI-enabled surveillance due to advanced health IT adoption, aging populations, mature infection control frameworks, and established public health reporting practices. Across these countries, procurement decisions increasingly center on interoperability, clinical validation, automation, cybersecurity, regulatory alignment, and measurable reduction in infection prevention workload.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable infection surveillance platforms that connect EHR, laboratory, pharmacy, bed management, device utilization, and public health reporting systems. Solutions should support recognized definitions, configurable rules, real-time alerts, role-based dashboards, and auditable workflows that help infection prevention teams move from passive monitoring to proactive intervention.

Vendors and providers should invest in AI governance, cybersecurity, data quality, and clinical validation before scaling predictive analytics. Leaders can strengthen adoption by aligning surveillance programs with antimicrobial stewardship, quality improvement, accreditation, and emergency preparedness goals. Clear ROI measurement should include reduced manual review time, faster outbreak detection, improved reporting accuracy, better targeting of prevention resources, and stronger readiness for regulatory audits.

Research Methodology

This executive summary is based on a structured research approach combining secondary research, expert interpretation, and evidence triangulation. Sources include publicly available guidance and datasets from the WHO, CDC, ECDC, national health ministries, peer-reviewed infection prevention literature, hospital quality reporting frameworks, digital health policy documents, and antimicrobial resistance surveillance programs.

The methodology evaluates demand drivers, regulatory requirements, technology adoption, regional healthcare infrastructure, interoperability readiness, and procurement priorities. Findings are validated by comparing global health indicators, surveillance frameworks, hospital digitization trends, infection prevention standards, and public health reporting requirements across regions, groups, and key countries to ensure evidence-led insights for infection surveillance solutions.

Conclusion

Infection surveillance solutions are moving from administrative tools to strategic platforms for patient safety, antimicrobial resistance control, and health system resilience. The most effective solutions combine automation, interoperability, clinically governed AI, secure data exchange, and actionable analytics to support infection prevention teams in real time.

As healthcare systems face persistent healthcare-associated infections and recurring infectious disease threats, demand will continue to shift toward scalable, secure, and evidence-based surveillance platforms. Organizations that invest early in integrated infection prevention intelligence will be better positioned to improve outcomes, meet reporting obligations, reduce preventable risk, and strengthen preparedness.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Infection Surveillance Solution Market, by Component
7.1. Introduction
7.2. Services
7.2.1. Consulting
7.2.2. Implementation & Integration
7.2.3. Maintenance & Upgrades
7.2.4. Training & Support
7.3. Software
7.3.1. Alert Management
7.3.2. Data Analytics
7.3.3. Reporting & Visualization
8. Infection Surveillance Solution Market, by Technology
8.1. Introduction
8.2. Artificial Intelligence And Machine Learning
8.2.1. Supervised Learning
8.2.2. Unsupervised Learning
8.3. Internet Of Things And Sensor Based
8.4. Traditional Rule Based
9. Infection Surveillance Solution Market, by Infection Type Monitored
9.1. Introduction
9.2. Bloodstream Infections
9.3. Surgical Site Infections
9.4. Urinary Tract Infections
9.5. Gastrointestinal Infections
9.6. Respiratory Infections
9.7. Device-Associated Infections
9.8. Multidrug-Resistant Organism Infections
10. Infection Surveillance Solution Market, by Deployment Mode
10.1. Introduction
10.2. Cloud
10.2.1. Hybrid Cloud
10.2.2. Private Cloud
10.2.3. Public Cloud
10.3. On Premises
10.3.1. Dedicated Servers
10.3.2. Virtualization
11. Infection Surveillance Solution Market, by Application
11.1. Introduction
11.2. Infection Control & HAI Surveillance
11.2.1. Bloodstream Infections
11.2.2. Surgical Site Infections
11.2.3. Urinary Tract Infections
11.3. Outbreak Management
11.3.1. Case Identification
11.3.2. Contact Tracing
11.3.3. Resource Allocation
11.4. Pathogen Genomics Analysis
11.5. Syndromic Surveillance
12. Infection Surveillance Solution Market, by End User
12.1. Introduction
12.2. Diagnostic Labs
12.3. Hospitals
12.4. Public Health Agencies
12.5. Research Institutes
13. Infection Surveillance Solution Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Infection Surveillance Solution Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Infection Surveillance Solution Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Alcidion Group Limited
17.3. Ascom Holding AG
17.4. Baxter International Inc.
17.5. Becton, Dickinson and Company
17.6. bioMérieux SA
17.7. BioVigil Healthcare Systems, Inc.
17.8. Ecolab Inc.
17.9. Environmental Systems Research Institute, Inc.
17.10. Epic Systems Corporation
17.11. Getinge AB
17.12. GOJO Industries, Inc.
17.13. HealthConnex
17.14. InductiveHealth Informatics
17.15. Inovalon, Inc.
17.16. InterSystems Corporation
17.17. Juvare, LLC
17.18. Koninklijke Philips N.V.
17.19. Medical Information Technology, Inc.
17.20. Medtronic plc
17.21. Midmark Corporation
17.22. Nosotech
17.23. Oracle Corporation
17.24. Palantir Technologies Inc.
17.25. PointClickCare Technologies Inc.
17.26. RLDatix
17.27. SafeQual Health, L.P.
17.28. SAS Institute Inc.
17.29. STERIS plc
17.30. sterloCare
17.31. SwipeSense, Inc.
17.32. Vitalacy, Inc.
17.33. Wolters Kluwer N.V.
17.34. ZulaFly, Inc.
18. Key Experts
List of Figures
FIGURE 1. Global Infection Surveillance Solution Market, Years Considered for the Study
FIGURE 2. Global Infection Surveillance Solution Market, Research Design
FIGURE 3. Global Infection Surveillance Solution Market, Research Framework
FIGURE 4. Global Infection Surveillance Solution Market, Data Triangulation
FIGURE 5. Global Infection Surveillance Solution Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Infection Surveillance Solution Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Infection Surveillance Solution Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Infection Surveillance Solution Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Infection Surveillance Solution Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Infection Surveillance Solution Market Size, by Infection Type Monitored, 2025 vs 2032 (%)
FIGURE 11. Global Infection Surveillance Solution Market Size, by Infection Type Monitored, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Infection Surveillance Solution Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 13. Global Infection Surveillance Solution Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Infection Surveillance Solution Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Infection Surveillance Solution Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Infection Surveillance Solution Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Infection Surveillance Solution Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Infection Surveillance Solution Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Infection Surveillance Solution Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Infection Surveillance Solution Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Infection Surveillance Solution Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Infection Surveillance Solution Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Infection Surveillance Solution Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Infection Surveillance Solution Market Segmentation & Coverage
TABLE 2. Global Infection Surveillance Solution Market Size, 2017-2032 (USD Million)
TABLE 3. Global Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Consulting Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Consulting Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Consulting Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Implementation & Integration Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Implementation & Integration Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Implementation & Integration Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Maintenance & Upgrades Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Maintenance & Upgrades Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Maintenance & Upgrades Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Training & Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Training & Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Training & Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Alert Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Alert Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Alert Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Data Analytics Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Data Analytics Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Data Analytics Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Reporting & Visualization Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Reporting & Visualization Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Reporting & Visualization Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 32. Global Artificial Intelligence And Machine Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Artificial Intelligence And Machine Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Artificial Intelligence And Machine Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Supervised Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Supervised Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Supervised Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Unsupervised Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Unsupervised Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Unsupervised Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Internet Of Things And Sensor Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Internet Of Things And Sensor Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Internet Of Things And Sensor Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Traditional Rule Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Traditional Rule Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Traditional Rule Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 48. Global Bloodstream Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Bloodstream Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Bloodstream Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Surgical Site Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Surgical Site Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Surgical Site Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Urinary Tract Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Urinary Tract Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Urinary Tract Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Gastrointestinal Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Gastrointestinal Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Gastrointestinal Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Device-Associated Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Device-Associated Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Device-Associated Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Multidrug-Resistant Organism Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Multidrug-Resistant Organism Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Multidrug-Resistant Organism Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 70. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Hybrid Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Hybrid Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Hybrid Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Private Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Private Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Private Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Public Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Public Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Public Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global On Premises Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global On Premises Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global On Premises Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Dedicated Servers Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Dedicated Servers Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Dedicated Servers Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Virtualization Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Virtualization Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Virtualization Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Global Infection Control & HAI Surveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Infection Control & HAI Surveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Infection Control & HAI Surveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Bloodstream Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Bloodstream Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Bloodstream Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Surgical Site Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Surgical Site Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Surgical Site Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Urinary Tract Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Urinary Tract Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Urinary Tract Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Outbreak Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Outbreak Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Outbreak Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Case Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Case Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Case Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Contact Tracing Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Contact Tracing Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Contact Tracing Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Resource Allocation Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Resource Allocation Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Resource Allocation Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Pathogen Genomics Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Pathogen Genomics Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Pathogen Genomics Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Syndromic Surveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Syndromic Surveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Syndromic Surveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Global Diagnostic Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Diagnostic Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Diagnostic Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Public Health Agencies Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Public Health Agencies Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Public Health Agencies Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Infection Surveillance Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Infection Surveillance Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. North America Infection Surveillance Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. North America Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 152. North America Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 153. North America Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 154. North America Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 155. North America Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 156. North America Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 157. North America Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 158. North America Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 159. North America Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 160. North America Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. North America Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 162. North America Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 163. North America Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Latin America Infection Surveillance Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Latin America Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 166. Latin America Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 167. Latin America Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 168. Latin America Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 169. Latin America Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 170. Latin America Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 171. Latin America Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 172. Latin America Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 173. Latin America Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 174. Latin America Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Latin America Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 176. Latin America Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 177. Latin America Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Europe Infection Surveillance Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Europe Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 180. Europe Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 181. Europe Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 182. Europe Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 183. Europe Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 184. Europe Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 185. Europe Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 186. Europe Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 187. Europe Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 188. Europe Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Europe Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 190. Europe Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 191. Europe Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Middle East Infection Surveillance Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Middle East Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 194. Middle East Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 195. Middle East Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 196. Middle East Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 197. Middle East Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 198. Middle East Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 199. Middle East Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 200. Middle East Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 201. Middle East Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 202. Middle East Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Middle East Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 204. Middle East Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 205. Middle East Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Africa Infection Surveillance Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Africa Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 208. Africa Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 209. Africa Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 210. Africa Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 211. Africa Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 212. Africa Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 213. Africa Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 214. Africa Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 215. Africa Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 216. Africa Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Africa Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 218. Africa Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 219. Africa Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Global Infection Surveillance Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. ASEAN Infection Surveillance Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. ASEAN Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 223. ASEAN Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 224. ASEAN Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 225. ASEAN Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. ASEAN Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 227. ASEAN Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 228. ASEAN Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 229. ASEAN Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 230. ASEAN Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 231. ASEAN Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. ASEAN Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 233. ASEAN Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 234. ASEAN Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. GCC Infection Surveillance Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. GCC Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 237. GCC Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 238. GCC Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 239. GCC Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 240. GCC Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 241. GCC Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 242. GCC Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 243. GCC Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 244. GCC Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 245. GCC Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. GCC Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 247. GCC Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 248. GCC Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. European Union Infection Surveillance Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. European Union Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 251. European Union Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 252. European Union Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 253. European Union Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 254. European Union Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 255. European Union Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 256. European Union Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 257. European Union Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 258. European Union Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 259. European Union Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. European Union Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 261. European Union Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 262. European Union Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. BRICS Infection Surveillance Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 264. BRICS Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 265. BRICS Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 266. BRICS Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 267. BRICS Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 268. BRICS Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 269. BRICS Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 270. BRICS Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 271. BRICS Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 272. BRICS Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 273. BRICS Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. BRICS Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 275. BRICS Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 276. BRICS Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. G7 Infection Surveillance Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. G7 Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 279. G7 Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 280. G7 Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 281. G7 Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 282. G7 Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 283. G7 Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 284. G7 Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 285. G7 Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 286. G7 Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 287. G7 Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. G7 Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 289. G7 Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 290. G7 Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. NATO Infection Surveillance Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 292. NATO Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 293. NATO Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 294. NATO Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 295. NATO Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 296. NATO Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 297. NATO Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 298. NATO Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 299. NATO Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 300. NATO Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 301. NATO Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. NATO Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 303. NATO Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 304. NATO Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Global Infection Surveillance Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 306. United States Infection Surveillance Solution Market Size, 2017-2032 (USD Million)
TABLE 307. United States Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 308. United States Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 309. United States Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 310. United States Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 311. United States Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 312. United States Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 313. United States Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 314. United States Infection Surveillance Solution Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 315. United States Infection Surveillance Solution Market Size, by On Premises, 2017-2032 (USD Million)
TABLE 316. United States Infection Surveillance Solution Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. United States Infection Surveillance Solution Market Size, by Infection Control & HAI Surveillance, 2017-2032 (USD Million)
TABLE 318. United States Infection Surveillance Solution Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 319. United States Infection Surveillance Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. Canada Infection Surveillance Solution Market Size, 2017-2032 (USD Million)
TABLE 321. Canada Infection Surveillance Solution Market Size, by Component, 2017-2032 (USD Million)
TABLE 322. Canada Infection Surveillance Solution Market Size, by Services, 2017-2032 (USD Million)
TABLE 323. Canada Infection Surveillance Solution Market Size, by Software, 2017-2032 (USD Million)
TABLE 324. Canada Infection Surveillance Solution Market Size, by Technology, 2017-2032 (USD Million)
TABLE 325. Canada Infection Surveillance Solution Market Size, by Artificial Intelligence And Machine Learning, 2017-2032 (USD Million)
TABLE 326. Canada Infection Surveillance Solution Market Size, by Infection Type Monitored, 2017-2032 (USD Million)
TABLE 327. Canada Infection Surveillance Solution Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 328. Canada Infec

Companies Mentioned

  • Abbott Laboratories
  • Alcidion Group Limited
  • Ascom Holding AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • BioVigil Healthcare Systems, Inc.
  • Ecolab Inc.
  • Environmental Systems Research Institute, Inc.
  • Epic Systems Corporation
  • Getinge AB
  • GOJO Industries, Inc.
  • HealthConnex
  • InductiveHealth Informatics
  • Inovalon, Inc.
  • InterSystems Corporation
  • Juvare, LLC
  • Koninklijke Philips N.V.
  • Medical Information Technology, Inc.
  • Medtronic plc
  • Midmark Corporation
  • Nosotech
  • Oracle Corporation
  • Palantir Technologies Inc.
  • PointClickCare Technologies Inc.
  • RLDatix
  • SafeQual Health, L.P.
  • SAS Institute Inc.
  • STERIS plc
  • sterloCare
  • SwipeSense, Inc.
  • Vitalacy, Inc.
  • Wolters Kluwer N.V.
  • ZulaFly, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.09 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.44 Billion
Compound Annual Growth Rate14.0%
Regions CoveredGlobal
No. of Companies Mentioned34

Related Topics

Related Reports

Infection Surveillance Solutions Market Size, Share, Trends and Forecast by Component, Deployment Type, End User, and Region, 2026-2034 - Product Image

Infection Surveillance Solutions Market Size, Share, Trends and Forecast by Component, Deployment Type, End User, and Region, 2026-2034

  • Report
  • 142 Pages
  • Global
From
Infection Surveillance Solutions - Global Strategic Business Report - Product Image

Infection Surveillance Solutions - Global Strategic Business Report

  • Report
  • 254 Pages
  • Global
From
Infection Surveillance Solutions - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Infection Surveillance Solutions - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Infection Surveillance Solutions Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Infection Surveillance Solutions Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 192 Pages
  • Global
From
Hospital Acquired Infection Control Market - Global Forecast 2026-2032 - Product Image

Hospital Acquired Infection Control Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From

About the Infection Surveillance Solutions Market

The Infection Surveillance Solutions market is a subset of the Infectious Disease Testing market, focusing on the development of solutions to monitor and track the spread of infectious diseases. These solutions are designed to provide healthcare professionals with the data and insights they need to identify and respond to potential outbreaks. Solutions may include software, hardware, and services that enable the collection, analysis, and sharing of data related to infectious diseases. The Infection Surveillance Solutions market is driven by the need to improve public health outcomes and reduce the economic impact of infectious diseases. Governments, healthcare providers, and other stakeholders are increasingly investing in solutions to better understand and respond to the spread of infectious diseases. Companies in the Infection Surveillance Solutions market include IBM, Epic Systems, Cerner Corporation, Allscripts, and Athenahealth. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.